Eesti -
eesti -
Ravimiamet
canocord 32 mg tablett
krka, d.d., novo mesto - kandesartaan - tablett - 32mg 30tk; 32mg 90tk; 32mg 60tk; 32mg 84tk; 32mg 14tk; 32mg 28tk; 32mg 98tk
Eesti -
eesti -
Ravimiamet
canocord 16 mg tablett
krka, d.d., novo mesto - kandesartaan - tablett - 16mg 90tk; 16mg 98tk; 16mg 14tk; 16mg 56tk; 16mg 60tk; 16mg 30tk; 16mg 84tk
Eesti -
eesti -
Ravimiamet
canocord 4 mg tablett
krka, d.d., novo mesto - kandesartaan - tablett - 4mg 14tk; 4mg 60tk; 4mg 28tk; 4mg 98tk; 4mg 90tk; 4mg 84tk
Eesti -
eesti -
Ravimiamet
canocord 8 mg tablett
krka, d.d., novo mesto - kandesartaan - tablett - 8mg 30tk; 8mg 90tk; 8mg 14tk; 8mg 56tk; 8mg 98tk; 8mg 84tk; 8mg 28tk; 8mg 60tk
Eesti -
eesti -
Ravimiamet
concor cor 2,5mg õhukese polümeerikattega tablett
merck kgaa - bisoprolool - õhukese polümeerikattega tablett - 2,5mg 30tk
Euroopa Liit -
eesti -
EMA (European Medicines Agency)
ronapreve
roche registration gmbh - casirivimab, imdevimab - covid-19 virus infection - suguhormoonid ja immunoglobuliinid, - ronapreve is indicated for:treatment of covid-19 in adults and adolescents aged 12 years and older weighing at least 40 kg who do not require supplemental oxygen and who are at increased risk of progressing to severe covid-19 (see section 4. prevention of covid-19 in adults and adolescents aged 12 years and older weighing at least 40 kg (see section 4. the use of ronapreve should take into account information on the activity of ronapreve against viral variants of concern. vt lõigud 4. 4 ja 5.
Eesti -
eesti -
Adama
legacy® pro
adama - suspensioonikontsentraat - diflufenikaan + kloortoluroon + pendimetaliin - herbitsiidid